Skip to main content
KOREAN DRUG CO., LTD. logo

KOREAN DRUG CO., LTD. — Investor Relations & Filings

Ticker · 014570 ISIN · KR7014570006 KO Manufacturing
Filings indexed 206 across all filing types
Latest filing 2026-05-19 Transaction in Own Shar…
Country KR South Korea
Listing KO 014570

About KOREAN DRUG CO., LTD.

http://www.kdpharma.co.kr/

Korean Drug Co., Ltd. is a pharmaceutical company engaged in the development, manufacturing, and marketing of a diverse range of healthcare products. The company's portfolio includes over-the-counter (OTC) and prescription (ETC) medicines, health supplements, cosmetics, and medical devices. It aims to provide comprehensive health solutions. The company is also active in research and development, maintaining a drug pipeline and conducting clinical trials in various therapeutic areas, including treatments for the nervous system.

Recent filings

Filing Released Lang Actions
자기주식처분결과보고서
Transaction in Own Shares Classification · 87% confidence The document is titled “자기주식처분결과보고서” (Report on disposal of treasury stock) and provides detailed data on the sale of the company’s own shares, including disposal period, number of shares, per-share price, total consideration, and post-disposal holdings. This matches the definition of “Transaction in Own Shares” (POS).
2026-05-19 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 92% confidence The document is a Korean "주요사항보고서(자기주식 처분 결정)" (Material Information Report on Decision to Dispose of Treasury Shares), detailing the number of treasury shares to be sold, disposal period, method (market sale/time block/off-market), purpose (retiree incentive payment), and related details. This is a report of the company selling its own shares (disposal of treasury stock), matching the definition of Transaction in Own Shares (Code: POS).
2026-05-18 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is a Korean 분기보고서 (quarterly report) covering the period January 1 to March 31, 2026 for a KOSDAQ-listed company. It contains substantive financial and operational data (capital changes, subsidiary information, business overview), not just an announcement or certification. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a brief announcement about a change in the company's listing section from '우량기업부' (Excellent Enterprise Division) to '중견기업부' (Mid-sized Enterprise Division) with a specified effective date. It contains no financial data, no detailed report, no management or board changes, no voting results, and no regulatory certifications. The document is very short (231 characters) and is a straightforward regulatory announcement about a listing category change. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-04-30 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 92% confidence The document is titled “자기주식처분결과보고서” (Report on the results of disposal of treasury shares) and provides detailed information on the disposal of the company’s own shares (dates, quantities, prices, post-transaction holdings). This corresponds exactly to a transaction in own shares report.
2026-04-07 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 95% confidence The document is titled “주요사항보고서(자기주식 처분 결정)” and details the decision by the company’s board to dispose of treasury shares (자기주식) – including number of shares, price basis, disposal method, and relevant disclosures. This falls squarely under a report of the company transacting in its own shares (share repurchase/issuance). Therefore it is classified as Transaction in Own Shares (Code: POS).
2026-03-31 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.